Integrative analysis of genome-wide DNA methylation and gene expression profiles associated with incident chronic kidney disease: the longitudinal Pros-RODAM cohort study
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Chronic kidney disease (CKD) is increasing rapidly in African populations, yet its molecular determinants remain poorly characterised. While epigenome-wide studies have been largely confined to high-income settings, comparable longitudinal epigenetic data from African populations are scarce, despite distinct genetic and environmental contexts. We conducted a longitudinal epigenome-wide study of CKD in an African population, integrating DNA methylation and gene expression to identify epigenetic changes associated with CKD and related kidney function decline. METHODS: DNA methylation was profiled using the Illumina EPIC (850K) array in 274 Ghanaian participants from the RODAM-Prospective cohort (92 incident CKD cases and 182 matched controls), providing 548 DNA methylation observations across baseline and ∼6-year follow-up, with high-quality DNA methylation data available at both timepoints. Epigenome-wide association studies (EWAS) were performed for incident CKD, change in estimated glomerular filtration rate (ΔeGFR), and change in urinary albumin-to-creatinine ratio (ΔACR), adjusting for demographic, clinical, and technical covariates. Differentially methylated regions (DMRs) were identified using bumphunter with family-wise error rate control. Differential gene expression (RNA-seq) analyses were conducted, followed by covariate-adjusted expression quantitative trait methylation (eQTM) analyses to link methylation with gene expression. FINDINGS: At baseline, significant differentially methylated positions (DMPs) were detected at INF2 (incident CKD), CLIP4 (ΔeGFR), and TMEM109 (ΔACR), alongside DMRs at HLA-DPB1 and SH2D1B (incident CKD) and ZFP57 and OR2T11 (ΔACR). At follow-up, a progression-related DMR in C4orf39/TRIM61 (ΔACR) was identified, with recurrent signals at hypermethylated HLA-DPB1 and hypomethylated ZFP57 and OR2T11 across timepoints. Integrative eQTM analysis revealed methylation-expression associations at recurrent loci including ZFP57, HLA-DRB5, SLC39A4, and SPATC1L, with predominantly inverse associations at ZFP57, HLA-DRB5, and SLC39A4, highlighting associations with metabolic and immune regulatory pathways. INTERPRETATION: We identified epigenetic changes associated with incident CKD and kidney function decline in an African population. These methylation signals, supported by gene expression patterns, highlight immune and kidney-related pathways associated with CKD risk and progression. Our findings provide a foundation for future studies investigating the potential of epigenetic markers in CKD risk stratification and prevention in African populations. FUNDING: European Commission; European Research Council.
Source: EBioMedicine
Authors: Muhulo Muhau Mungamba, Andrea Venema, Manasa Kalya Purushothama, Karlijn A.C. Meeks, Felix P. Chilunga, Eva L. van der Linden, Charles F. Hayfron-Benjamin, Constance R. Sewani-Rusike, Liffert Vogt, Bert-Jan van den Born, Samuel N. Darko, Ellis Owusu-Dabo, Benedicta N. Nkeh-Chungag, Charles Agyemang, Peter Henneman
Institutions: Amsterdam Public Health, Amsterdam University Medical Centers, University of Amsterdam, Walter Sisulu University, Amsterdam Reproduction Development, Amsterdam UMC Location University of Amsterdam, University of Ghana, Korle Bu Teaching Hospital, Amsterdam Cardiovascular Sciences, Kwame Nkrumah University of Science and Technology, Johns Hopkins University, Johns Hopkins Medicine
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: chronic kidney disease, DNA methylation, gene expression, epigenome-wide association study, expression quantitative trait methylation, renal function decline, estimated glomerular filtration rate, albumin-creatinine ratio, HLA-DPB1, ZFP57, HLA-DRB5, SLC39A4, differentially methylated regions, African populations, Ghana
Open Access status: gold
Estimated APC paid: $5,780
OpenAlex ID: W7226002464
